Study Conduct

Medidata to acquire Mytrus

Tuesday, April 18, 2017

Medidata, a global provider of cloud-based solutions and data analytics for clinical research, has agreed to acquire Mytrus, an eClinical technology company specializing in patient-centered electronic informed consent (eConsent) and virtual trials.

[Read More]

Clinical SCORE presents Partner of Choice

Friday, April 14, 2017

Clinical SCORE presents an innovative process for measuring the effectiveness of Medical Affairs (MA) teams. Partner of Choice addresses the pharmaceutical industry’s need for a non-monetary way to assess performance while maintaining regulatory compliance and to assist teams with the critical insights necessary to deliver greater value to key opinion leaders (KOLs).

[Read More]

Science march planned for April 22

Tuesday, April 11, 2017

On Saturday, April 22, the March for Science will take place in more than 400 cities across the globe to celebrate the many scientific advances that have improved the health and well-being of people worldwide. Research!America will be on the ground participating in the Washington, D.C. event, and some of the satellite marches in Los Angeles, California; Oklahoma City, Oklahoma; and Salt Lake City, Utah. 

[Read More]

HealthCarePoint’s mRSI initiative reaches 10-year milestone

Wednesday, April 5, 2017

HealthCarePoint (HCP) has announced that the modified Rankin Scale (mRS) standards are now available to healthcare and clinical research professionals on every continent and in over 12 languages through the BlueCloud Education Network. The achievement marks a 10-year milestone for the company, which is working to standardize healthcare training and certification for healthcare professionals internationally. 

[Read More]

TransCelerate calls out pharmacovigilance operational challenges

Tuesday, April 4, 2017

TransCelerate BioPharma has added Pharmacovigilance to its portfolio, establishing two new global initiatives: 1.) Interpretation of Pharmacovigilance Regulations and 2.) Value of Safety Information Data Sources. Both initiatives aim to create solutions that will reduce resource inefficiencies, enhance information exchange with global health authorities and improve patient safety to drive more value for patients.

[Read More]

Collaborative definition of patient centricity by AstraZeneca, patients and carers

Friday, March 31, 2017

AstraZeneca has announced that BMJ Innovations has published the first collaborative definition of patient centricity for the pharmaceutical industry. The definition was co-developed with patients and caregivers using research led by AstraZeneca and patient community advocates to ensure a deep understanding of patient needs and values. Ten associated patient-centric principles were also identified and published in BMJ Innovations to provide the pharmaceutical industry with a consistent reference point to sustain meaningful and mutually beneficial engagement with patients. Wider testing of these outputs among U.S. and European patient communities confirmed their validity.

[Read More]